JPRN-UMIN000001729未知未知
Prevention and regression of carotid artery IMT with Cilostazol and Pioglitazone use in atherosclerosis with type 2 diabetes - PRECIOUS
CHIBAKEN SAISEIKAI NARASINO HOSPITAL internal medicine0 个研究点目标入组 400 人开始时间: 2009年3月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. HbA1c and over 10% 2. Medical history or presumptive of carotid arterial reconstruction 3. BNP and over 100 4. Early stage of stroke 5. Arterial fibrillation 6. Under anti-platelet therapy other than aspirin 7. Receiving warfarin-potassium therapy 8. Congestive heart failure 9. Severe hepatic disfunction or renal disfunction 10. Severe infections disease, injury, pre or post operation 11. Severe ketosis, diabetic coma, type 1 diabetes mellitus 12. Pts who are bleeding 13. Drug allergies or medical history of hypersensitivity to the investigational drugs 14. Pregnant or lactating women, or women who wish to become pregnant 15. Others whom the investigator judges inappropriate as subjects for this study
研究者
相似试验
Unknown
不适用
Carotid Atherosclerosis In Newly Diagnosed Type 2 IndividualsType II Diabetes Mellitus Without Mention of ComplicationNCT01898572Hospital Clinic of Barcelona200
已完成
3 期
Carotid artery compression in preventing postoperative cognitive dysfunction in patients undergoing mitral valve replacement surgery: A randomized clinical trialPACTR202401599878859Cairo University Hospitals120
已完成
4 期
A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.Diabetic Peripheral AngiopathyNCT05906199SK Chemicals Co., Ltd.105
招募中
不适用
Study of endothelial dysfunction in patients of chronic kidney disease not on dialysisCTRI/2013/09/003979Department of Nephrology200
已完成
不适用
Carotid Intima-media Thickness (IMT) and Large-vessel Atherosclerosis by Multidetector Computed Tomography (MDCT)Type 2 DiabetesNCT00949169Eulji University Hospital71